Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BÜHLMANN Laboratories AG is a Swiss-based specialist in in vitro diagnostics (IVD) and a global leader in fecal calprotectin testing. Founded in 1976, the company focuses on providing high-quality diagnostic assays for inflammatory bowel disease (IBD), therapeutic drug monitoring (TDM), and cellular allergy. Their flagship products include the BÜHLMANN fCAL® ELISA and the IBDoc® platform, which allows patients to monitor their calprotectin levels using a smartphone. BÜHLMANN also offers a range of assays for neuroimmunology and clinical chemistry, serving clinical laboratories and healthcare providers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratory Dr. Buhlmann.